dendrimer gene delivery (UL School of Pharmacy)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namedendrimer gene delivery (UL School of Pharmacy)
Drug Alias Nameanticancer dendrimer (UL School of Pharmacy)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsImmune System DiseasesGenetic Diseases, InbornNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of London
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesGenetic Diseases, InbornNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A